These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27075761)

  • 1. Hydroxocobalamin-attributed risk of oxalate nephropathy: evidence is not sufficient to change the recommended management of cyanide toxicity by fire smoke inhalation.
    Mégarbane B
    Intensive Care Med; 2016 Jul; 42(7):1197-8. PubMed ID: 27075761
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxocobalamin-induced oxalate nephropathy after smoke inhalation.
    Hamdini L; Ydee A; Larsen S; Gibier JB; Azar R; Petit V
    J Nephrol; 2023 Jun; 36(5):1443-1445. PubMed ID: 36853498
    [No Abstract]   [Full Text] [Related]  

  • 3. Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade.
    Fortin JL; Giocanti JP; Ruttimann M; Kowalski JJ
    Clin Toxicol (Phila); 2006; 44 Suppl 1():37-44. PubMed ID: 16990192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wine-Colored Plasma and Urine from Hydroxocobalamin Treatment.
    Wong SL; Pudek M; Li D
    J Gen Intern Med; 2017 Feb; 32(2):225-226. PubMed ID: 27338592
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients.
    Legrand M; Michel T; Daudon M; Benyamina M; Ferry A; Soussi S; Maurel V; Chaussard M; Chaouat M; Mimoun M; Verine J; Mallet V; Mebazaa A;
    Intensive Care Med; 2016 Jun; 42(6):1080-1. PubMed ID: 26891675
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of hydroxocobalamin in smoke inhalation victims.
    Houeto P; Borron SW; Sandouk P; Imbert M; Levillain P; Baud FJ
    J Toxicol Clin Toxicol; 1996; 34(4):397-404. PubMed ID: 8699553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation.
    Borron SW; Baud FJ; Barriot P; Imbert M; Bismuth C
    Ann Emerg Med; 2007 Jun; 49(6):794-801, 801.e1-2. PubMed ID: 17481777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric cyanide poisoning by fire smoke inhalation: a European expert consensus. Toxicology Surveillance System of the Intoxications Working Group of the Spanish Society of Paediatric Emergencies.
    Mintegi S; Clerigue N; Tipo V; Ponticiello E; Lonati D; Burillo-Putze G; Delvau N; Anseeuw K;
    Pediatr Emerg Care; 2013 Nov; 29(11):1234-40. PubMed ID: 24196100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyanide antidotes and fire toxicology.
    Kulig K
    N Engl J Med; 1991 Dec; 325(25):1801-2. PubMed ID: 1944486
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxocobalamin in cyanide poisoning.
    Thompson JP; Marrs TC
    Clin Toxicol (Phila); 2012 Dec; 50(10):875-85. PubMed ID: 23163594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost impact of hydroxocobalamin in the treatment of patients with known or suspected cyanide poisoning due to smoke inhalation from closed-space fires.
    Sanders KN; Aggarwal J; Stephens JM; Michalopoulos SN; Dalton D; Lewis DE; Kahn SA
    Burns; 2022 Sep; 48(6):1325-1330. PubMed ID: 34903402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of cyanocobalamin and hydroxocobalamin during treatment of cyanide intoxication.
    Demedts P; Wauters A; Franck F; Neels H
    Lancet; 1995 Dec 23-30; 346(8991-8992):1706-7. PubMed ID: 8551845
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyanide poisoning and cardiac disorders: 161 cases.
    Fortin JL; Desmettre T; Manzon C; Judic-Peureux V; Peugeot-Mortier C; Giocanti JP; Hachelaf M; Grangeon M; Hostalek U; Crouzet J; Capellier G
    J Emerg Med; 2010 May; 38(4):467-76. PubMed ID: 20185266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation.
    Borron SW; Baud FJ; Mégarbane B; Bismuth C
    Am J Emerg Med; 2007 Jun; 25(5):551-8. PubMed ID: 17543660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of hydroxocobalamin use for the treatment of suspected cyanide toxicity secondary to smoke inhalation.
    Kamta J; Maynard K; Schult RF; Bell DE; Jones CMC; Acquisto NM
    Burns; 2024 Feb; 50(1):157-166. PubMed ID: 37777459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focus on smoke inhalation--the most common cause of acute cyanide poisoning.
    Eckstein M; Maniscalco PM
    Prehosp Disaster Med; 2006; 21(2):s49-55. PubMed ID: 16771012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empiric management of cyanide toxicity associated with smoke inhalation.
    O'Brien DJ; Walsh DW; Terriff CM; Hall AH
    Prehosp Disaster Med; 2011 Oct; 26(5):374-82. PubMed ID: 22336184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of cyanide toxicity in patients with burns.
    MacLennan L; Moiemen N
    Burns; 2015 Feb; 41(1):18-24. PubMed ID: 24994676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired methemoglobinemia after hydroxocobalamin administration in a patient with burns and inhalation injury.
    Jiwani AZ; Bebarta VS; Cancio LC
    Clin Toxicol (Phila); 2018 May; 56(5):370-372. PubMed ID: 28969436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discoloration of skin and urine after treatment with hydroxocobalamin for cyanide poisoning.
    Cescon DW; Juurlink DN
    CMAJ; 2009 Jan; 180(2):251. PubMed ID: 19153403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.